- Home
- VIR vs PGRE Comparison
VIR vs PGRE Comparison
Compare VIR & PGRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- PGRE
- Stock Information
- Founded
- VIR 2016
- PGRE 1978
- Country
- VIR United States
- PGRE United States
- Employees
- VIR N/A
- PGRE N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- PGRE Real Estate Investment Trusts
- Sector
- VIR Health Care
- PGRE Real Estate
- Exchange
- VIR Nasdaq
- PGRE Nasdaq
- Market Cap
- VIR 706.4M
- PGRE 1.3B
- IPO Year
- VIR 2019
- PGRE 2014
- Fundamental
- Price
- VIR $5.23
- PGRE $6.81
- Analyst Decision
- VIR Strong Buy
- PGRE Hold
- Analyst Count
- VIR 8
- PGRE 4
- Target Price
- VIR $30.25
- PGRE $5.63
- AVG Volume (30 Days)
- VIR 1.2M
- PGRE 3.5M
- Earning Date
- VIR 07-31-2025
- PGRE 07-30-2025
- Dividend Yield
- VIR N/A
- PGRE N/A
- EPS Growth
- VIR N/A
- PGRE N/A
- EPS
- VIR N/A
- PGRE N/A
- Revenue
- VIR $20,861,000.00
- PGRE $711,729,000.00
- Revenue This Year
- VIR N/A
- PGRE $1.41
- Revenue Next Year
- VIR $0.62
- PGRE N/A
- P/E Ratio
- VIR N/A
- PGRE N/A
- Revenue Growth
- VIR N/A
- PGRE 49.28
- 52 Week Low
- VIR $4.32
- PGRE $3.75
- 52 Week High
- VIR $14.45
- PGRE $6.89
- Technical
- Relative Strength Index (RSI)
- VIR 51.12
- PGRE 74.06
- Support Level
- VIR $5.20
- PGRE $5.96
- Resistance Level
- VIR $6.23
- PGRE $6.72
- Average True Range (ATR)
- VIR 0.29
- PGRE 0.18
- MACD
- VIR 0.03
- PGRE 0.04
- Stochastic Oscillator
- VIR 38.08
- PGRE 98.39
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About PGRE Paramount Group Inc.
Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district (CBD) submarkets of New York City and San Francisco. The company operates in two geographical segments New York and San Francisco. The company derives nearly all of its majority of revenue from rental income.